Clinical Trial Update: Evaluation of Solifenacin in the Treatment of OAB Symptoms in Patients Who Have Successfully Undergone GreenLight Photoselective Vaporization of the Prostate (PVP) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating solifenacin for overactive bladder symptoms in patients who have undergone GreenLight PVP surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Solifenacin (solifenacin)

Snippet

Sponsor: Seattle Urology Research Center | Conditions: Urinary Frequency, Urinary Urgency | Phase 4 | Status: UNKNOWN